10 Dogs of the Dow Dividend Stocks to Invest in
Dividend-focused investors are often drawn to stocks with high yields, shaping their strategies around acquiring such investments.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 7,560,199 | $1,225,206,136 | +8% | 0.5% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 5,271,507 | $854,300,426 | +36% | 1.04% |
| 3. | 4,016,600 | $650,930,196 | +52% | 0.12% | |
| 4. | AQR Capital Management Cliff Asness | 3,158,963 | $509,919,950 | -6% | 0.7% |
| 5. | 2,182,700 | $353,728,362 | +32% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $147.22 | 1,000 | Director | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | Director | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | Director | 5,000 | 2019-12-13 | Filing | |
| $139.68 | 3,000 | Director | 3,000 | 2019-06-11 | Filing | |
| $133.76 | 748 | Director | 6,537 | 2018-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.06 | 5,635 | Officer | 18,973 | 2024-08-30 | Filing | |
| $162.16 | 8,891 | Officer | 15,043 | 2024-03-13 | Filing | |
| $156.27 | 59,397 | Officer | 141,416 | 2024-02-09 | Filing | |
| $170.32 | 20,000 | Officer | 102,696 | 2023-07-25 | Filing | |
| $172.00 | 14,698 | Officer | 87,747 | 2023-07-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 229,387,626 | $35,954,216,499 | 0.78% | |
| 2. | 186,308,341 | $29,201,969,345 | 0.74% | |
| 3. | 132,904,295 | $20,831,419,198 | 1.01% | |
| 4. | 51,256,785 | $8,014,191,369 | 0.83% | |
| 5. | 41,659,479 | $6,529,707,241 | 0.57% |
News See All
11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now
In the face of economic uncertainty, consumer preferences in the beauty industry are changing.
Dividend Kings List: Top 15
Dividend Kings are a distinguished group of companies that have achieved at least 50 consecutive years of dividend increases.
Billionaire Ray Dalio's Bridgewater Is Crazy About These 15 Stocks
Ray Dalio, a seasoned global macro investor with over 50 years of experience, founded Bridgewater Associates from his two-bedroom apartment in New York City and led the firm for most of its 47-year history...
10 Best Dividend Aristocrat Stocks To Buy Right Now
Investors usually buy stocks with the expectation that their value will increase as the company grows more profitable. However, stocks can offer additional advantages.
8 Most Promising Healthcare Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Why Johnson & Johnson (JNJ)’s Legal Issues Could Wrap Up Quickly
The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999.
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
10 Worst Performing Dow Stocks Year-to-Date
After the disastrous performance of 2022, the market has recovered better than expected and is on a growth trajectory.
Johnson & Johnson (NYSE:JNJ) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Johnson & Johnson's Third Quarter 2024 Earnings Conference Call.
Billionaire Hedge Funds
